Transient pseudothrombocytopenia associated with immune heparin-induced thrombocytopenia complicated by pulmonary embolism

• References

• 1 Warkentin TE, Greinacher A, Gruel Y. et al. on behalf of the Scientific, Standardization Committee of the International Society on Thrombosis, Haemostasis Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis. J Thromb Haemost 2011; 09: 2498-2500.
• 2 Greinacher A, Farner B, Kroll H. et al. Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis A retrospective analysis of 408 patients. Thromb Haemost 2005; 94: 132-135.
• 3 Bizzaro N. EDTA-dependent pseudothrombocytopenia: A clinical and epidemiological study of 112 cases, with 10-year follow-up. Am J Hematol 1995; 50: 103-109.
• 4 Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 2001; 344: 1286-1292.
• 5 Schwarzinger I, Speiser W, Lubenow N. et al. Heparin-platelet factor (PF) 4 antibodies in patients with pseudothrombocytopenia: coincidence or association?. Thromb Haemost 2000; 84: 1123-1124.
• 6 Martin-Toutain I, Settegrana C, Ankri A. High levels of heparin-platelet factor 4 antibodies in patients with pseudothrombocytopenia: risk of misdiagnosis. Thromb Haemost 2009; 07: 1416-1418.
• 7 Balcik OS, Akdeniz D, Cipil H. et al. Heparin platelet factor 4 antibody positivity in pseudothrombocytopenia. Clin Appl Thromb Hemost 2012; 18: 92-95.